NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00050687 2011-01-28Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory MalignanciesTitan PharmaceuticalsPhase 1/2 Terminated